Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
1 hedge funds and large institutions have $43 invested in Syneos Health, Inc. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $991
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Financial Synergies Wealth Advisors
Houston,
Texas
|
-$991 |
SYNH Hedge Fund Activity: Q1 2024 in Review
1 of the 6,966 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2024, worth a combined $43 — down 96% from $1.03K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SYNH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Financial Synergies Wealth Advisors, exiting entirely with an estimated $991 sold.
- 1 institutional investor held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $43 of Syneos Health, Inc. Class A Common Stock stock for Q1 2024, down 96% quarter-over-quarter.
- 0 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2024 was Financial Synergies Wealth Advisors, an estimated $991 sold.
Based on aggregated 13F filings for Q1 2024.